BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
2.010
-0.090 (-4.29%)
At close: Jan 14, 2025, 4:00 PM
2.110
+0.100 (4.98%)
After-hours: Jan 14, 2025, 7:45 PM EST
BioVie Market Cap
BioVie has a market cap or net worth of $35.66 million as of January 14, 2025. Its market cap has decreased by -22.31% in one year.
Market Cap
35.66M
Enterprise Value
19.80M
1-Year Change
-22.31%
Ranking
Category
Stock Price
$2.01
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $35.66M, a decrease of -31.42%. That is a compound annual growth rate of -8.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2025 | 35.70M | 0.56% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.26B |
| UnitedHealth Group | 479.18B |
| Novo Nordisk | 385.14B |
| Johnson & Johnson | 342.03B |
| AbbVie | 309.55B |
| Merck & Co. | 251.07B |
| AstraZeneca | 207.72B |
| Thermo Fisher Scientific | 207.43B |